The UK Sovereign AI Fund is in talks to back a £500m funding round for a drug discovery startup, according to Sifted. The state-backed fund, which focuses on AI-related investments, is considering participating in the raise.
If completed, the deal would represent a notable commitment from the fund to the drug discovery sector, an area where AI is increasingly applied. The startup's name and other financial terms have not been disclosed.
Talks are ongoing, and the source does not indicate that an agreement is close. The outcome remains uncertain.